Cargando…

The Impact of Pre-Chemotherapy Body Composition and Immunonutritional Markers on Chemotherapy Adherence in Stage III Colorectal Cancer Patients

Patients with colorectal cancer (CRC) often fail to complete full-course chemotherapy with a standard dose due to various reasons. This study aimed to determine whether body composition affects chemotherapy adherence in patients with CRC. The medical records of 107 patients with stage III CRC who un...

Descripción completa

Detalles Bibliográficos
Autores principales:	Lee, Soohyeon, Kang, Dong Hyun, Ahn, Tae Sung, Kim, Seung Soo, Yun, Jong Hyuk, Kim, Hyun Jung, Seo, Seoung Hee, Kim, Tae Wan, Kong, Hye Jeong, Baek, Moo Jun
Formato:	Online Artículo Texto
Lenguaje:	English
Publicado:	MDPI 2023
Materias:	Article
Acceso en línea:	https://www.ncbi.nlm.nih.gov/pmc/articles/PMC9962672/ https://www.ncbi.nlm.nih.gov/pubmed/36835962 http://dx.doi.org/10.3390/jcm12041423

Ejemplares similares

Clinical influence of neoadjuvant chemoradiotherapy on immunonutritional status in locally advanced rectal cancer
por: Lee, Soohyeon, et al.
Publicado: (2023)

Efficacy of immunonutritional supplement after neoadjuvant chemotherapy in patients with esophageal cancer
por: Luo, Chao, et al.
Publicado: (2022)

Class III β-tubulin is a predictive marker for taxane-based chemotherapy in recurrent and metastatic gastric cancer
por: Hwang, Jun-Eul, et al.
Publicado: (2013)

ERCC1 as a Predictive Marker for FOLFOX Chemotherapy in an Adjuvant Setting
por: Kim, Chee Young, et al.
Publicado: (2015)

Pancreatoduodenectomy following neoadjuvant chemotherapy in duodenal adenocarcinoma
por: Seo, Dongjin, et al.
Publicado: (2023)

Effect of preoperative immunonutrition on outcomes of colon cancer surgery: study protocol for a randomized controlled trial
por: Lee, Soo Young, et al.
Publicado: (2020)

Prognostic Value of Axillary Nodal Ratio after Neoadjuvant Chemotherapy of Doxorubicin/Cyclophosphamide Followed by Docetaxel in Breast Cancer: A Multicenter Retrospective Cohort Study
por: Kim, Se Hyun, et al.
Publicado: (2016)

Impact of adjuvant chemotherapy for gliomatosis cerebri
por: Kong, Doo-Sik, et al.
Publicado: (2010)

Prognosis of stage III colorectal carcinomas with FOLFOX adjuvant chemotherapy can be predicted by molecular subtype
por: Kwon, Yujin, et al.
Publicado: (2017)

Tumor Marker Kinetics as Prognosticators in Patients with Unresectable Gallbladder Adenocarcinoma Undergoing Palliative Chemotherapy
por: Lee, Jae Woo, et al.
Publicado: (2018)

Prognostic factors for renal function deterioration during palliative first-line chemotherapy for metastatic colorectal cancer: a retrospective study
por: Lim, Ah Reum, et al.
Publicado: (2022)

The Role of Neutrophil-lymphocyte Ratio and Platelet-lymphocyte Ratio in Predicting Neoadjuvant Chemotherapy Response in Breast Cancer
por: Kim, Hee Yeon, et al.
Publicado: (2019)

The significance of immunonutrition nutritional support in patients undergoing postoperative adjuvant chemotherapy for lung cancer: case–control study
por: Akcam, Tevfik Ilker, et al.
Publicado: (2023)

Analysis of treatment outcomes according to the cycles of adjuvant chemotherapy in gastric cancer: a retrospective nationwide cohort study
por: Kim, Tae-Hwan, et al.
Publicado: (2022)

The Importance of immunonutrition in children
por: Berni Canani, Roberto, et al.
Publicado: (2014)

The Role of Immunonutrition in Patients
por: Cintoni, Marco, et al.
Publicado: (2023)

Procarbazine, CCNU, and Vincristine Chemotherapy in Gliomatosis Cerebri
por: Lee, Hyun Gon, et al.
Publicado: (2014)

Genomic Consideration in Chemotherapy-Induced Ovarian Damage and Fertility Preservation
por: Kim, Seongmin, et al.
Publicado: (2021)

External validation of chemotherapy response score system for histopathological assessment of tumor regression after neoadjuvant chemotherapy in tubo-ovarian high-grade serous carcinoma
por: Lee, Jung-Yun, et al.
Publicado: (2017)

Short-term outcomes of Early versus conventional adjuvant chemotherapy in stage III colon cancer: randomized clinical trial
por: Lee, Kyung Ha, et al.
Publicado: (2023)

Analysis of thromboembolic events in patients with non-small cell lung cancer who received adjuvant chemotherapy: single-center real-world data
por: Kim, Tae-Hwan, et al.
Publicado: (2022)

Surrogate decision making of chemotherapy consent: do we really provide informed consent of chemotherapy for patients?
por: Kwon, Jung Hye, et al.
Publicado: (2019)

First-line chemotherapy in very elderly patients with metastatic pancreatic cancer: Gemcitabine monotherapy vs combination chemotherapy
por: Han, Sung Yong, et al.
Publicado: (2020)

Oncologic Outcomes of Postoperative Chemoradiotherapy Versus Chemotherapy Alone in Stage II and III Upper Rectal Cancer
por: Yoon, Ji Eun, et al.
Publicado: (2019)

Trastuzumab-based palliative chemotherapy for HER2-positive gastric cancer: a single-center real-world data
por: Kim, Tae-Hwan, et al.
Publicado: (2021)

Clinical relevance and prognostic role of preoperative cell-free single-stranded DNA concentrations in colorectal cancer patients
por: Song, Hyun Soo, et al.
Publicado: (2021)

Prognostic implication of ABC transporters and cancer stem cell markers in patients with stage III colon cancer receiving adjuvant FOLFOX-4 chemotherapy
por: Han, Song-Hee, et al.
Publicado: (2019)

Effects of pre-operative enteral immunonutrition for esophageal cancer patients treated with neoadjuvant chemoradiotherapy: protocol for a multicenter randomized controlled trial (point trial, pre-operative immunonutrition therapy)
por: Cao, Yuqin, et al.
Publicado: (2022)

Optimal time interval from surgery to adjuvant chemotherapy in gastric cancer
por: Ahn, Geon Tae, et al.
Publicado: (2020)

Incidence and Clinical Outcomes of Febrile Neutropenia in Adult Cancer Patients with Chemotherapy Using Korean Nationwide Health Insurance Database
por: Kim, Dalyong, et al.
Publicado: (2021)

Impact of Lymph Node Ratio on Oncologic Outcomes in ypStage III Rectal Cancer Patients Treated with Neoadjuvant Chemoradiotherapy followed by Total Mesorectal Excision, and Postoperative Adjuvant Chemotherapy
por: Koo, Taeryool, et al.
Publicado: (2015)

Clinical value of an adenosine triphosphate-based chemotherapy response assay in resectable stage III colorectal cancer
por: Kim, Chan Dong, et al.
Publicado: (2019)

Immunonutrition in Orthopedic and Traumatic Patients
por: Gregori, Pietro, et al.
Publicado: (2023)

Prognostic Impact of Immunonutritional Status Changes During Preoperative Chemoradiation in Patients With Rectal Cancer
por: Lee, Yong Joon, et al.
Publicado: (2016)

Timing of Adjuvant Chemotherapy in Colorectal Cancer Patients
por: Baek, Moo-Jun
Publicado: (2013)

Concurrent Gonadotropin-Releasing Hormone Agonist Administration with Chemotherapy Improves Neoadjuvant Chemotherapy Responses in Young Premenopausal Breast Cancer Patients
por: Kim, Hee Jeong, et al.
Publicado: (2015)

Chemotherapy adherence is a favorable prognostic factor for elderly patients with multiple myeloma who are treated with a frontline bortezomib-containing regimen
por: Cho, Hee-Jeong, et al.
Publicado: (2018)

Increased Malignant Microcalcifications after Neoadjuvant Chemotherapy in Advanced Breast Cancer
por: Shin, Gi Won, et al.
Publicado: (2016)

Chemoradiotherapy versus radiotherapy alone following induction chemotherapy for elderly patients with stage III lung cancer
por: Kim, Dong-Yun, et al.
Publicado: (2019)

Single Center Experience With Hyperthermic Intraperitoneal Chemotherapy
por: Kim, Woo Ram, et al.
Publicado: (2017)

Cannot write session to /tmp/vufind_sessions/sess_luip772airguv394mipeupbn16